PTC Therapeutics (PTCT) Stock
PTC Therapeutics (PTCT) closed at $63.49 on Nov 13, 2026; its Tenet Score is 74 of 100 against 409 Healthcare peers.
23 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $63.49
- Nov 13, 2026
- Market cap
- $5.3B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 58.80 – 90.87
- low → high
- Tenet Score
- 74/100
- Solid · 409 Healthcare peers
Industry: Drugs · see every company filed here →
PTC Therapeutics Inc scores 74/100. Solid. Strongest on value and growth versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ~ Piotroski F-Score
- ~ Munger Compounders
- ✓ Magic Formula
- ~ Graham Defensive
- ~ Quality Compounder
- ~ Drawdown Context
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of d…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| ImmunityBio IncIBRX | 53 | $6.4B |
| Ligand Pharmaceuticals, Inc.LGND | 46 | $6.2B |
| Grifols SAGRFS | 50 | $6.0B |
| Dianthus Therapeutics IncDNTH | 63 | $5.2B |
| Liquidia CorpLQDA | 46 | $5.1B |
| Edgewise Therapeutics IncEWTX | 68 | $5.0B |
| Cogent Biosciences IncCOGT | 33 | $5.0B |
| Travere Therapeutics IncTVTX | 43 | $4.9B |
| Ionis Pharmaceuticals IncIONS | 29 | $4.8B |
| Definium Therapeutics Inc.DFTX | 50 | $4.4B |
Common questions
What sector and industry is PTC Therapeutics in?
PTC Therapeutics is in the Healthcare sector and the Drugs industry.
What is PTC Therapeutics' Tenet Score?
PTC Therapeutics' Tenet Score is 74 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




